238 related articles for article (PubMed ID: 27358408)
1. JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.
Millena AC; Vo BT; Khan SA
J Biol Chem; 2016 Aug; 291(34):17964-76. PubMed ID: 27358408
[TBL] [Abstract][Full Text] [Related]
2. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
3. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
Kimbrough-Allah MN; Millena AC; Khan SA
Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer.
Merz VW; Arnold AM; Studer UE
World J Urol; 1994; 12(2):96-8. PubMed ID: 7522082
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
6. MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.
Luo Y; Vlaeminck-Guillem V; Baron S; Dallel S; Zhang CX; Le Romancer M
J Exp Clin Cancer Res; 2021 Aug; 40(1):270. PubMed ID: 34446068
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
8. JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
Mehraein-Ghomi F; Lee E; Church DR; Thompson TA; Basu HS; Wilding G
Prostate; 2008 Jun; 68(9):924-34. PubMed ID: 18386285
[TBL] [Abstract][Full Text] [Related]
9. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
10. The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1.
Koo AS; Chiu R; Soong J; Dekernion JB; Belldegrun A
J Urol; 1992 Oct; 148(4):1314-8. PubMed ID: 1404666
[TBL] [Abstract][Full Text] [Related]
11. Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.
Elliott B; Millena AC; Matyunina L; Zhang M; Zou J; Wang G; Zhang Q; Bowen N; Eaton V; Webb G; Thompson S; McDonald J; Khan S
Cancer Lett; 2019 Apr; 448():155-167. PubMed ID: 30763715
[TBL] [Abstract][Full Text] [Related]
12. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
Chen D; Reierstad S; Fang F; Bulun SE
Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
[TBL] [Abstract][Full Text] [Related]
13. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
15. Role of TGF-β-induced Claudin-4 expression through c-Jun signaling in non-small cell lung cancer.
Rachakonda G; Vu T; Jin L; Samanta D; Datta PK
Cell Signal; 2016 Oct; 28(10):1537-44. PubMed ID: 27424491
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation.
Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC
Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971
[TBL] [Abstract][Full Text] [Related]
17. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
Palcy S; Bolivar I; Goltzman D
J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
[TBL] [Abstract][Full Text] [Related]
18. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor.
Li L; Hu JS; Olson EN
J Biol Chem; 1990 Jan; 265(3):1556-62. PubMed ID: 2104845
[TBL] [Abstract][Full Text] [Related]
19. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
20. Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells.
Wang H; Xie Z; Scott RE
J Cell Biol; 1996 Nov; 135(4):1151-62. PubMed ID: 8922393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
